Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

35.340
+0.3000.86%
Volume:38.21M
Turnover:1.35B
Market Cap:77.68B
PE:-18.34
High:36.100
Open:35.080
Low:34.800
Close:35.040
52wk High:36.100
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:0.62
T/O Rate:1.74%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.55
PE(LYR):-18.34
PS:11.73

Loading ...

GENSCRIPT BIO Surges Over 5% Following Partner Legend Biotech's ASCO 2026 Research Presentations

Stock News
·
May 27

Stock Track | GenScript Bio Soars 5.57% Intraday on ASCO Data Releases and Valuation Sentiment

Stock Track
·
May 27

Movement Alert|GenScript Biotech Rises 5.12% in Regular Trading, Legend Biotech ASCO Data Releases Boost Sentiment

Market Focus
·
May 27

Genscript Biotech (01548): Legend Biotech Unveils Multiple Research Findings at 2026 ASCO Annual Meeting

Stock News
·
May 22

Stock Track | GENSCRIPT BIO Soars 5.45% Intraday on Sector Optimism and Strong Associate Performance

Stock Track
·
May 13

GENSCRIPT BIO Surges Over 5% as Associate Legend Biotech Reports Narrowed Loss and Strong CARVYKTI® Sales Growth

Stock News
·
May 13

GENSCRIPT BIO Announces Legend Biotech’s Q1 2026 Results Filing with U.S. SEC

Bulletin Express
·
May 12

A Look At Genscript Biotech (SEHK:1548) Valuation After Recent Share Price Momentum

Simply Wall St.
·
May 09

Genscript Biotech marginally expands issued share base after option exercise

Bulletin Express
·
May 06

Is It Time To Reassess Genscript Biotech (SEHK:1548) After Its Recent Share Price Recovery?

Simply Wall St.
·
Apr 25

Genscript Biotech Governance Reset Puts Shareholder Rights Under Fresh Focus

Simply Wall St.
·
Apr 23

GenScript leaders await EY Entrepreneur Of The Year New Jersey awards results

Reuters
·
Apr 23

GENSCRIPT BIO (01548) Surges Over 8% in Morning Trading Following Lilly's $70 Billion In Vivo CAR-T Acquisition

Stock News
·
Apr 21

BUZZ-Genscript Biotech climbs as cancer drug CARVYKTI generated $597 mln sales

Reuters
·
Apr 15

GENSCRIPT BIO Reports $597 Million Net Trade Sales for CARVYKTI® in Quarter Ending March 31, 2026

Stock News
·
Apr 14

GenScript announces availability of 2025 ESG report

Reuters
·
Apr 14

Genscript: Legend Biotech Posts US$597.00 Million CARVYKTI® Net Sales for Q1 2026

Bulletin Express
·
Apr 14

A Look At GenScript Biotech (SEHK:1548) Valuation After New DNA Data Storage Collaboration With Mimulus

Simply Wall St.
·
Apr 13

GenScript Reports 2025 ESG Progress: 10% Emissions Drop, 58% Female Workforce and SBTi-Aligned Net-Zero Roadmap

Bulletin Express
·
Apr 13

GENSCRIPT BIO Sets 5 June 2026 AGM; Shareholders to Vote on FY-2025 Statements, Director Re-elections and 20% Issuance Mandate

Bulletin Express
·
Apr 13